يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Hormigo, Adília"', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
    دورية أكاديمية
    A phase I trial of VEGF-A inhibition combined with PD-L1 blockade for recurrent glioblastoma

    المؤلفون: Chiu, Daniel, Qi, Jingjing, Thin, Tin Htwe, Garcia-Barros, Monica, Lee, Brian, Hahn, Mary, Mandeli, John, Belani, Puneet, Nael, Kambiz, Rashidipour, Omid, Ghatan, Saadi, Hadjipanayis, Constantinos G, Yong, Raymund L, Germano, Isabelle M, Brody, Rachel, Tsankova, Nadejda M, Gnjatic, Sacha, Kim-Schulze, Seunghee, Hormigo, Adilia

    المصدر: Cancer Research Communications, vol 3, iss 1

    مصطلحات موضوعية: Brain Cancer, Brain Disorders, Rare Diseases, Neurosciences, Cancer, Prevention, Clinical Research, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Good Health and Well Being, Humans, Middle Aged, Bevacizumab, Glioblastoma, Antibodies, Monoclonal, Vascular Endothelial Growth Factor A, B7-H1 Antigen

    جغرافية الموضوع: 130 - 139

    وصف الملف: application/pdf

    العلاقة: qt8162m7xn; https://escholarship.org/uc/item/8162m7xnTest

    الإتاحة: https://escholarship.org/uc/item/8162m7xnTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)

    المؤلفون: Galanis, Evanthia, Anderson, S Keith, Twohy, Erin, Butowski, Nicholas A, Hormigo, Adilia, Schiff, David, Omuro, Antonio, Jaeckle, Kurt A, Kumar, Shaji, Kaufmann, Timothy J, Geyer, Susan, Kumthekar, Priya U, Campian, Jian, Giannini, Caterina, Buckner, Jan C, Wen, Patrick Y

    المساهمون: Galanis, Evanthia, Anderson, S Keith, Twohy, Erin, Butowski, Nicholas A, Hormigo, Adilia, Schiff, David, Omuro, Antonio, Jaeckle, Kurt A, Kumar, Shaji, Kaufmann, Timothy J, Geyer, Susan, Kumthekar, Priya U, Campian, Jian, Giannini, Caterina, Buckner, Jan C, Wen, Patrick Y

    مصطلحات موضوعية: CD105, TRC105, angiogenesi, bevacizumab, glioblastoma

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35664553; info:eu-repo/semantics/altIdentifier/wos/WOS:000852789900052; volume:4; issue:1; firstpage:1; lastpage:11; numberofpages:11; journal:NEURO-ONCOLOGY ADVANCES; https://hdl.handle.net/11585/901909Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85134976099; https://academic.oup.com/noa/article/4/1/vdac041/6563099?login=trueTest

    الإتاحة: https://doi.org/10.1093/noajnl/vdac041Test
    https://hdl.handle.net/11585/901909Test
    https://academic.oup.com/noa/article/4/1/vdac041/6563099?login=trueTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Use of Anti-angiogenic Agents in Glioblastoma Treatment.

    المؤلفون: Hormigo, Adília1

    المصدر: Neurology Alert. Oct2008, Vol. 27 Issue 2, p15-15. 3/4p.

    مصطلحات موضوعية: *GLIOBLASTOMA multiforme treatment, *BRAIN tumors, *BEVACIZUMAB, *CANCER invasiveness, *TUMORS, *INTRACRANIAL hematoma, *VENOUS thrombosis


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث